Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of SYR-472, once daily
(QD), in subjects with type 2 diabetes mellitus who have not achieved glycemic control with
diet and exercise, or by taking metformin.